Allergic Rhinitis Market - PowerPoint PPT Presentation

About This Presentation
Title:

Allergic Rhinitis Market

Description:

Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes. – PowerPoint PPT presentation

Number of Views:68

less

Transcript and Presenter's Notes

Title: Allergic Rhinitis Market


1
Allergic Rhinitis
  • Market insight, Epidemiology and Market forecast
    2027

2
Allergic Rhinitis
  • Allergic rhinitis, also known as hay fever, is a
    type of inflammation in the nose which occurs
    when the immune system overreacts to allergens in
    the air. Signs and symptoms include a runny or
    stuffy nose, sneezing, red, itchy, and watery
    eyes, and swelling around the eyes.

3
Allergic rhinitis
Allergy and immunology
Specialty
Stuffy nose, sneezing, red, itchy and watery
eyes, swelling around the eyes
Symptoms
Genetic and environmental factors
Causes
Frequency
20 ( Western countries )
4
Classification
01
Allergic rhinitis may be seasonal or perennial.
02
Seasonal allergic rhinitis occurs in particular
during pollen seasons. It does not usually
develop until after 6 years of age.
03
Perennial allergic rhinitis occurs throughout the
year. This type of allergic rhinitis is commonly
seen in younger children.
It may also be classified as Mild-Intermittent,
Moderate-Severe intermittent, Mild-Persistent,
and Moderate-Severe Persistent.
04
5
Market Insights
Pharmacotherapy and immunotherapy are recommended
for treating Allergic Rhinitis
Targeted immunotherapy is effective in changing
the natural course of Allergic Rhinitis.
Launch of therapies such as Omalizumab (Novartis
Pharmaceuticals) and GSP 301 (Glenmark Pharma)
shall fuel the growth of the market.
Market size of allergic rhinitis in the US was
found to be xxx in 2016.
The market size of allergic rhinitis shall
increase at a CAGR of XX during forecast period
(2018-2027)
6
Emerging Therapy Analysis
Omalizumab
GSP 301
Launch of emerging therapies such as
Omalizumab (Novartis Pharmaceuticals)
GSP 301 (Glenmark Pharmaceuticals Ltd)
And other effective therapies, are expected to
change the treatment landscape of Allergic
Rhinitis in upcoming years.
7
COMPLETE INFORMATION
For complete information please click the link
below
CLICK HERE
Or write us at info_at_delveinsight.com
8
ABOUT DELVEINSIGHT
ABOUT DELVEINSIGHT
Delveinsight , market research consulting
firm provides end to end comprehensive solutions
to the life science industry. We help our
customers in best decision-making through our
expertise in research analysis comes out with
unmatched data forecasts.
MISSION
To be the most trusted market research
business consulting firm worldwide. To be the
renowned premier data driven solutions
providers among pharma biotech companies.
VISION
  • Insight across value chain to help organization
    make important business decision through the use
    and analysis of actionable market intelligence.

9
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com